Collplant

Developer of recombinant human collagen for regenerative medicine and aesthetics

placeNess Ziona, Center District, Israel calendar_todayFounded 2004 groups73 employees language collplant.com

Innovation

31 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Textiles & paper, Operations & transport; filing pace slowing. Cited 4,298 times.

YearFilings
20157
20168
20176
20185
20196
20208
20217
20224
20234
20245
20254
20261

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Private equity233%
Other / undisclosed233%
Coming soon